Oramed Pharmaceuticals
ORMP
ORMP
51 hedge funds and large institutions have $15.4M invested in Oramed Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% less funds holding
Funds holding: 56 → 51 (-5)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
Holders
51
Holding in Top 10
–
Calls
$43K
Puts
$26K
Top Buyers
| 1 | +$962K | |
| 2 | +$872K | |
| 3 | +$481K | |
| 4 |
VF
Virtu Financial
New York
|
+$68K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$60.4K |
Top Sellers
| 1 | -$1.22M | |
| 2 | -$640K | |
| 3 | -$245K | |
| 4 |
Squarepoint
New York
|
-$82.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$72.4K |